Prospective epidemiological, molecular, and genetic characterization of a novel coronavirus disease in the Val Venosta/Vinschgau: the CHRIS COVID-19 study protocol. (17th February 2022)

• Record Type: Journal Article
• Authors: Pattaro, Cristian; Barbieri, Giulia; Foco, Luisa; Weichenberger, Christian X.; Biasiotto, Roberta; De Grandi, Alessandro; Fuchsberger, Christian; Egger, Clemens; Amon, Vera S. C.; Hicks, Andrew A.; Mian, Michael; Mahlknecht, Angelika; Lombardo, Stefano; Meier, Horand; Weiss, Helmuth; Rainer, Robert; Dejaco, Christian; Weiss, Günter; Lavezzo, Enrico; Crisanti, Andrea; Pizzato, Massimo; Domingues, Francisco S.; Mascalzoni, Deborah; Gögele, Martin; Melotti, Roberto; Pramstaller, Peter P.
• Is Part Of: Pathogens and global health. Volume 116:Number 2(2022)
• Page Start: 128
• Page End: 136
• Publication Date: 2022-02-17
• Subjects: COVID-19 -- SARS-CoV-2 -- Cooperative Health Research In South Tyrol (CHRIS) study -- general population -- novel coronavirus; Communicable diseases -- Periodicals; Public health -- International cooperation -- Periodicals; World health -- Periodicals; 362.1969
• DOI: 10.1080/20477724.2021.1978225
• Languages: English
• ISSNs: 2047-7724

Abstract

ABSTRACT: The COVID-19 pandemic has been threatening the healthcare and socioeconomic systems of entire nations. While population-based surveys to assess the distribution of SARS-CoV-2 infection have become a priority, pre-existing longitudinal studies are ideally suited to assess the determinants of COVID-19 onset and severity.The Cooperative Health Research In South Tyrol (CHRIS) study completed the baseline recruitment of 13, 393 adults from the Venosta/Vinschgau rural district in 2018, collecting extensive phenotypic and biomarker data, metabolomic data, densely imputed genotype and whole-exome sequencing data.Based on CHRIS, we designed a prospective study, called CHRIS COVID-19, aimed at: 1) estimating the incidence of SARS-CoV-2 infections; 2) screening for and investigating the determinants of incident infection among CHRIS participants and their household members; 3) monitoring the immune response of infected participants prospectively.An online screening questionnaire was sent to all CHRIS participants and their household members. A random sample of 1450 participants representative of the district population was invited to assess active (nasopharyngeal swab) or past (serum antibody test) infections. We prospectively invited for complete SARS-CoV-2 testing all questionnaire completers gauged as possible cases of past infection and their household members. In positive tested individuals, antibody response is monitored quarterly for one year. Untested and negative participants receive the screening questionnaire every four weeks until gauged as possible incident cases or till the study end.Originated from a collaboration between researchers and community stakeholders, the CHRIS COVID-19 study aims at generating knowledge about the epidemiological, molecular, and genetic characterization of COVID-19 and its long-term sequelae.